MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,342,630 | -65.5% | 1,663,000 | -23.2% | 2.82% | -55.3% |
| Q1 2024 | $9,697,533 | +76.5% | 2,164,628 | -8.6% | 6.30% | +103.7% |
| Q4 2023 | $5,493,760 | +4242.9% | 2,368,000 | +2277.3% | 3.09% | +3537.6% |
| Q3 2023 | $126,501 | -48.7% | 99,607 | +66.0% | 0.08% | -53.3% |
| Q1 2023 | $246,600 | -95.6% | 60,000 | -93.7% | 0.18% | -94.7% |
| Q4 2022 | $5,567,000 | -3.8% | 950,000 | +165.6% | 3.43% | +64.2% |
| Q1 2021 | $5,787,000 | -68.7% | 357,689 | -48.5% | 2.09% | -58.5% |
| Q4 2020 | $18,467,000 | +48.6% | 694,000 | +4.0% | 5.02% | +48.9% |
| Q3 2020 | $12,429,000 | -16.0% | 667,500 | +5.5% | 3.38% | -21.1% |
| Q2 2020 | $14,801,000 | +206.8% | 632,500 | -23.6% | 4.28% | +82.9% |
| Q1 2020 | $4,824,000 | – | 827,500 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |